Skip to main content
SpringerLink
Log in

Benign Prostatic Hyperplasia

  • Living reference work entry
  • First Online:
Handbook of Medical and Health Sciences in Developing Countries

  • 184 Accesses

Abstract

Benign prostatic hyperplasia (BPH) is a common disease worldwide that develops in men older than 40 years. It is also known as disease of aging men. The prevalence of BPH increases with age and varies in different regions of the world. Inflammation, hormonal alterations, metabolic factors, and age-related remodeling process contribute in pathophysiology of BPH. Common symptoms of BPH include nocturia, urinary urgency, weak stream of urine, dribbling, and incomplete bladder emptying. Aging, family history, and metabolic disorders are risk factors for BPH. Complications include bladder stones, urinary tract infections (UTIs), and bladder and kidney damage. International prostate symptom score (IPSS), digital rectal examination (DRE), and post-void residual urine volume (PVR) are recommended tests for diagnosis of BPH. BPH can be treated through surveillance, medical therapy, and various surgical procedures. The aim of this chapter is to describe BPH with its complications, epidemiology, management, interventions, recommendation, and guidelines in context of developing countries.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Abdikarim Hussein Mohamed, H. A. M. (2020). Open prostatectomy: The safety and efficacy of this procedure in developing countries. Urology & Nephrology Open Access Journal, 8(2), 53–55. https://doi.org/10.15406/unoaj.2020.08.00275

    Article  Google Scholar 

  • Bahia, L. R., Araujo, D. V., Pepe, C., Trindade, M., Camargo, C. M., & Javaroni, V. (2012). Cost-effectiveness analysis of medical treatment of benign prostatic hyperplasia in the Brazilian public health system. International Braz J Urol, 38(5), 595–605.

    Article  PubMed  Google Scholar 

  • Bali, S. (2018). Barriers to development of telemedicine in developing countries. Telehealth. IntechOpen.

    Google Scholar 

  • Benign Prostatic Hyperplasia. (2021). Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/benign-prostatic-hyperplasia-bph

  • Benign Prostatic Hyperplasia (BPH). (2021). mayoclinic.org/diseases-conditions/benign-prostatic-hyperplasia/symptoms-causes/syc-20370087

  • Benign Prostatic Hyperplasia Pathophysiology. (2021). https://bphnews.com/prostatic-hyperplasia-pathophysiology/

  • Berroukche, A., Bendahmane-Salmi, M., & Kandouci, B. A. (2013). Evaluation of clinical benign prostatic hyperplasia frequency. About 783 cases in the Western Algerian hospital.

    Google Scholar 

  • Bid, H. K., Konwar, R., & Singh, V. (2008). Benign prostatic hyperplasia: Is it a growing public health concern for India? Indian Journal of Medical Sciences, 62(9), 375–376.

    Google Scholar 

  • Braeckman, J., & Denis, L. (2017). Management of BPH then 2000 and now 2016–From BPH to BPO. Asian Journal of Urology, 4(3), 138–147.

    Article  PubMed  PubMed Central  Google Scholar 

  • Calogero, A. E., Burgio, G., Condorelli, R. A., Cannarella, R., & La Vignera, S. (2019). Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male, 22(1), 12–19.

    Article  PubMed  Google Scholar 

  • Chertack, N., Lotan, Y., Mayorga, C., & Mauck, R. (2020). Implementation of a urology e-consult service at a safety net county hospital. Urology Practice, 7(6), 448–453.

    Article  Google Scholar 

  • Cpm13th Bph. (2021). https://pdfcoffee.com/cpm13th-bph-pdf-free.html

  • Da Silva, R., Rados, D., Dos Santos, E., Katz, N., Harzheim, E., Polanczyk, C., & Neto, B. (2018). MP51-06 teleconsultation support patients with benign prostatic hyperplasia being discharged from specialized care: A randomized noninferiority study. The Journal of Urology, 199(4S), e686–e687.

    Article  Google Scholar 

  • Das, K., & Buchholz, N. (2019). Benign prostate hyperplasia and nutrition. Clinical Nutrition ESPEN, 33, 5–11.

    Article  CAS  PubMed  Google Scholar 

  • de la Rosette, J. J., Alivizatos, G., Madersbacher, S., Perachino, M., Thomas, D., Desgrandchamps, F., & de Wildt, M. (2001). EAU guidelines on benign prostatic hyperplasia (BPH). European Urology, 40(3), 256–263.

    Article  PubMed  Google Scholar 

  • Elshal, A. M., Mekkawy, R., Laymon, M., Barakat, T. S., Elsaadany, M. M., El-Assmy, A., & El-Nahas, A. R. (2016). Holmium laser enucleation of the prostate for treatment for large-sized benign prostate hyperplasia; is it a realistic endourologic alternative in developing country? World Journal of Urology, 34(3), 399–405.

    Article  PubMed  Google Scholar 

  • Ertel, P., Adalig, B., Demircan, I., Lartey, B., & Manyak, M. J. (2016). Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: The Prostate Research on Behaviour and Education (PROBE) II survey. International Journal of Clinical Practice, 70(10), 870–880.

    Article  PubMed  Google Scholar 

  • Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Abyu, G. Y., Ahmed, M. B., Aichour, A. N., & Aichour, I. (2017). Global, regional, and national burden of neurological disorders during 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. The Lancet Neurology, 16(11), 877–897.

    Article  Google Scholar 

  • Foo, K. T. (2015). Diagnosis and treatment of benign prostate hyperplasia in Asia. Translational Andrology and Urology, 4(4), 478.

    PubMed  PubMed Central  Google Scholar 

  • Gettman, M., Rhee, E., & Spitz, A. (2016). Telemedicine in urology. AUA White Pap, 1, 3081.

    Google Scholar 

  • Guevara-Cuellar, C. A., Parody-Rúa, E., Garcia-Perdomo, H. A., & Arenas-Duque, A. (2018). Cost-effectiveness of combination therapy versus monotherapy in benign prostatic hyperplasia: A colombian experience. Value in Health Regional Issues, 17, 174–182.

    Article  PubMed  Google Scholar 

  • Harkaway, R., & Issa, M. (2006). Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasia. Prostate Cancer and Prostatic Diseases, 9(3), 204–214.

    Article  CAS  PubMed  Google Scholar 

  • In the Name of Prostate Health: GSK Pioneers World BPH Day. (2018). https://manilastandard.net/lifestyle/home-living/269479/in-the-name-of-prostate-health-gsk-pioneers-world-bph-day.html

  • Karera, A., Maguranyanga, E. F., Nleya, S., & Chingarande, G. (2014). The effectiveness of ultrasound in early detection of benign prostatic hypertrophy, a case study of Chitungwiza, Zimbabwe. World Journal of Medical Sciences, 10(2), 122–128.

    Google Scholar 

  • Kirby, R. S. (2000). The natural history of benign prostatic hyperplasia: What have we learned in the last decade? Urology, 56(5), 3–6.

    Article  CAS  PubMed  Google Scholar 

  • Launer, B. M., McVary, K. T., Ricke, W. A., & Lloyd, G. L. (2021). The rising worldwide impact of benign prostatic hyperplasia. BJU International, 127(6), 722.

    Article  PubMed  Google Scholar 

  • Lee, S. W. H., Chan, E. M. C., & Lai, Y. K. (2017). The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis. Scientific Reports, 7(1), 1–10.

    Google Scholar 

  • Lepor, H. (2004). Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Reviews in Urology, 6(Suppl 9), S3.

    PubMed  PubMed Central  Google Scholar 

  • Levi A Deters, R. A. C., Leveillee, R. J., Moore, C. R., & Patel, V. R. (2021). How common is benign prostatic hyperplasia (BPH)? https://www.medscape.com/answers/437359-90389/how-common-is-benign-prostatic-hyperplasia-bph

  • Lokeshwar, S. D., Harper, B. T., Webb, E., Jordan, A., Dykes, T. A., Neal, D. E., Jr., Terris, M. K., & Klaassen, Z. (2019). Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Translational Andrology and Urology, 8(5), 529.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lu, S.-H., & Chen, C.-S. (2014). Natural history and epidemiology of benign prostatic hyperplasia. Formosan Journal of Surgery, 47(6), 207–210.

    Article  Google Scholar 

  • Madersbacher, S., Sampson, N., & Culig, Z. (2019). Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: A mini-review. Gerontology, 65(5), 458–464.

    Article  CAS  PubMed  Google Scholar 

  • Management of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms: AUA Guideline 2021. (2021). American Urological Association. https://www.auanet.org/guidelines/guidelines/benign-prostatic-hyperplasia-(bph)-guideline#x8217

  • McConnell, J. D. (1994). Benign prostatic hyperplasia: Diagnosis and treatment. US Department of Health and Human Services, Public Health Service, Agency.

    Google Scholar 

  • Medical Management of Symptomatic Benign Prostatic Hyperplasia. (2021). https://database.inahta.org/article/2964

  • Metzler, I., Bayne, D., Chang, H., Jalloh, M., & Sharlip, I. (2020). Challenges facing the urologist in low-and middle-income countries. World Journal of Urology, 38(11), 2987–2994.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mochtar, C., Umbas, R., Soebadi, D., Rasyid, N., Noegroho, B., & Poernomo, B. (2015). Panduan Penatalaksanaan Klinis Pembesarakan Prostat Jinak. Iakatan Ahli Urologi Indonesia.

    Google Scholar 

  • Morselli, S., Liaci, A., Nicoletti, R., Pecoraro, A., Gemma, L., Polverino, P., Zaccaro, C., Sebastianelli, A., Serni, S., & Laguna, P. (2020). The use of a novel smartphone app for monitoring male luts treatment during the COVID-19 outbreak. Prostate Cancer and Prostatic Diseases, 23(4), 724–726.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Napalkov, P., Maisonneuve, P., & Boyle, P. (1995). Worldwide patterns of prevalence and mortality from benign prostatic hyperplasia. Urology, 46(3), 41–46.

    Article  CAS  PubMed  Google Scholar 

  • Novara, G., Galfano, A., Gardi, M., Ficarra, V., Boccon-Gibod, L., & Artibani, W. (2006). Critical review of guidelines for BPH diagnosis and treatment strategy. European Urology Supplements, 5(4), 418–429.

    Article  Google Scholar 

  • Oh, S.-J. (2013). Unsolved issues in managing benign prostatic hyperplasia. Korean Journal of Urology, 54(6), 349–350.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ojewola, R., Oridota, E., Balogun, O., Alabi, T., Ajayi, A., Olajide, T., Tijani, K., Jeje, E., Ogunjimi, M., & Ogundare, E. (2017). Prevalence of clinical benign prostatic hyperplasia amongst community-dwelling men in a South-Western Nigerian rural setting: A cross-sectional study. African Journal of Urology, 23(2), 109–115.

    Article  Google Scholar 

  • Ozturk, A., Serel, T. A., Kosar, A., & Kecelioglu, M. (2000). Prevalence of benign prostatic hyperplasia in Turkish men admitted to the urology department. Progrès en Urologie, 10(4), 568.

    CAS  PubMed  Google Scholar 

  • Park, H. J., Won, J. E. J., Sorsaburu, S., Rivera, P. D., & Lee, S. W. (2013). Urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and LUTS/BPH with erectile dysfunction in Asian men: a systematic review focusing on tadalafil. The World Journal of Men’s Health, 31(3), 193–207.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pharmacopoeia, I. (1996). Controller of publications. New Delhi, 2, 764.

    Google Scholar 

  • Rahman, F., Putra, I. B., Mochtar, C. A., & Rasyid, N. (2019). Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia. Prostate International, 7(1), 35–40.

    Article  PubMed  Google Scholar 

  • Rahman, S. (2018). The characteristics of benign prostatic hyperplasia (BPH) in Rumah Sakit Umum Haji Medan. Journal of Public Health and Epidemiology, 10(1), 16–20.

    Article  Google Scholar 

  • Rai, P., Srivastava, A., Dhayal, I. R., & Singh, S. (2017). Comparison of safety, efficacy and cost effectiveness of photoselective vaporization with bipolar vaporization of prostate in benign prostatic hyperplasia. Current Urology, 11(2), 103–109.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rencz, F., Kovács, Á., Brodszky, V., Gulácsi, L., Németh, Z., Nagy, G. J., Nagy, J., Buzogány, I., Böszörményi-Nagy, G., & Majoros, A. (2015). Cost of illness of medically treated benign prostatic hyperplasia in Hungary. International Urology and Nephrology, 47(8), 1241–1249.

    Article  PubMed  Google Scholar 

  • Scott, R. E., & Mars, M. (2015). Telehealth in the developing world: Current status and future prospects. Smart Homecare Technol Telehealth, 3(1), 25–37.

    Article  Google Scholar 

  • Shabbir, A., Khan, U. T., Nisar, D., Rath, P. K., Kumari, C., Zehra, T., & Hasan, S. M. (2023). Frequency and trends of prostatic diseases in a subset of Karachi population: A retrospective study. Editorial Board, 12(1), 17–23.

    Google Scholar 

  • Speakman, M. J., & Cheng, X. (2014). Management of the complications of BPH/BOO. Indian Journal of Urology: IJU: Journal of the Urological Society of India, 30(2), 208.

    Article  PubMed  Google Scholar 

  • Tanguay, S., Awde, M., Brock, G., Casey, R., Kozak, J., Lee, J., Nickel, J. C., & Saad, F. (2009). Diagnosis and management of benign prostatic hyperplasia in primary care. Canadian Urological Association Journal, 3(3 Suppl 2), S92.

    PubMed  PubMed Central  Google Scholar 

  • Tantiwong, A., Nuanyong, C., Vanprapar, N., Swasdipala, P., & Chittapraphai, S. (2002). Benign prostatic hyperplasia in elderly Thai men in an urban community: The prevalence, natural history and health related behavior. Journal of the Medical Association of Thailand= Chotmaihet thangphaet, 85(3), 356–360.

    PubMed  Google Scholar 

  • Tomašković, I., Tomić, M., Nikles, S., Neretljak, I., & Miličić, V. (2015). Croatian urologists’ clinical practice and compliance with guidelines in the management of non-neurogenic male lower urinary tract symptoms. Acta Clinica Croatica, 54(4), 453–457.

    PubMed  Google Scholar 

  • Tsukamoto, T., & Masumori, N. (1997). Epidemiology and natural history of benign prostatic hyperplasia. International Journal of Urology, 4(3), 233–246.

    Article  CAS  PubMed  Google Scholar 

  • Tubaro, A. (2006). Micronutrients and BPH. European Urology, 3(50), 413–415.

    Article  Google Scholar 

  • Udeh, E. I., Ofoha, C. G., Adewole, D. A., & Nnabugwu, I. I. (2016). A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model. BMC Cancer, 16(1), 1–9.

    Article  Google Scholar 

  • Ugwumba, F., Ozoemena, O., Okoh, A., Echetabu, K., & Mbadiwe, O. (2014). Transvesical prostatectomy in the management of benign prostatic hyperplasia in a developing country. Nigerian Journal of Clinical Practice, 17(6), 797–801.

    Article  CAS  PubMed  Google Scholar 

  • Wu, N., Sun, J., Yu, P., & Sun, Z. (2012). Chinese urologists’ views of practice patterns in the diagnosis and treatment of benign prostatic hyperplasia: a nationwide survey. International Neurourology Journal, 16(4), 191.

    Article  PubMed  PubMed Central  Google Scholar 

  • Xia, S.-J., Cui, D., & Jiang, Q. (2012). An overview of prostate diseases and their characteristics specific to Asian men. Asian Journal of Andrology, 14(3), 458.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yeboah, E. (2016). Prevalence of benign prostatic hyperplasia and prostate cancer in Africans and Africans in the diaspora. Journal of the West African College of Surgeons, 6(4), 1.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, 72388, Saudi Arabia

    Tauqeer Hussain Mallhi & Yusra Habib Khan

  2. Department of Pharmacy, Lahore College Women University, Lahore, Pakistan

    Erum Ijaz

  3. Department of Medicinal Chemistry, Faculty of Pharmacy, Uppsala University, Uppsala, 75123, Sweden

    Muhammad Hammad Butt

  4. Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan

    Shahid Shah

  5. Department of Pharmacy, The Women University Multan, Multan, Pakistan

    Kanwal Rehman

  6. Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan

    Muhammad Salman

  7. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University, Xi’an, China

    Faiz Ullah

  8. School of Pharmacy, Faculty of Health and Medical Sciences, Taylors University, Selangor, Malaysia

    Ahsan Aftab Raja

  9. Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan

    Amjad Khan

  10. Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan

    Tahir Mehmood Khan

Authors
  1. Tauqeer Hussain Mallhi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erum Ijaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Muhammad Hammad Butt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yusra Habib Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shahid Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kanwal Rehman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Muhammad Salman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Faiz Ullah
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ahsan Aftab Raja
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Amjad Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tahir Mehmood Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yusra Habib Khan .

Editor information

Editors and Affiliations

  1. College of Pharmacy, University of Science and Technology of Fujairah, Fujairah, United Arab Emirates

    Yaser Mohammed Al-Worafi

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Mallhi, T.H. et al. (2023). Benign Prostatic Hyperplasia. In: Al-Worafi, Y.M. (eds) Handbook of Medical and Health Sciences in Developing Countries . Springer, Cham. https://doi.org/10.1007/978-3-030-74786-2_87-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-74786-2_87-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-74786-2

  • Online ISBN: 978-3-030-74786-2

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation